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Azoline moieties in the backbones of peptidic
natural products are important structural motifs
that contribute to diverse bioactivities. Some azo-
line-containing peptides (Az-peptides) are produced
from ribosomally synthesized precursor peptides, in
which cysteine, serine, and threonine residues are
converted to their corresponding azolines by post-
translational modification through a cyclodehydra-
tase. We have devised an in vitro biosynthesis
system of Az-peptides, referred to as the FIT-PatD
(flexible in vitro translation) system, by the integra-
tion of a cell-free translation system with the post-
translational cyclodehydratase PatD. This system
enabled the ‘‘one-pot’’ synthesis of a wide variety
of Az-peptide derivatives expressed from synthetic
DNA templates. The FIT-PatD system also facilitated
mutagenesis studies on a wide array of precursor
peptide sequences, unveiling unique in vitro sub-
strate tolerance of PatD.
INTRODUCTION
The azolines thiazoline and oxazoline are 5-membered ring
heterocycles found in the backbones of many peptidic natural
products (Kalyon et al., 2011; McIntosh et al., 2009; Melby
et al., 2011; Roy et al., 1999b). In some cases, the translationma-
chinery first synthesizes precursor peptides, and Cys, Ser, and
Thr (C/S/T) residues are converted to thiazoline, oxazoline, and
methyloxazoline, respectively, by posttranslational cyclodehy-
dratases. The resulting azoline-containing peptides (Az-pep-
tides) are often further processed by other enzyme families to
yield mature secondary metabolites containing azolines, azoles,
or both. Recent genome-mining studies of relevant gene clusters
have revealed the wide distribution of Az-peptide biosynthetic
pathways in myriad prokaryotes (Donia et al., 2008; Lee et al.,
2008). The enzymatic modification of C/S/T residues incorpo-
rates nonpeptidic moieties into the polyamide backbone,
thereby endowing the final products with unique structural motifs766 Chemistry & Biology 21, 766–774, June 19, 2014 ª2014 Elsevierand conformational strains. As a consequence, these heterocy-
cles contribute to the diverse bioactivities of this class of natural
products (Degnan et al., 1989; Drechsel and Jung, 1998; Hong
and Luesch, 2012; Melby et al., 2011; Scholz et al., 2011).
For posttranslational cyclodehydration, the precursor pep-
tides commonly require two sequence elements, a leader pep-
tide (LP) and core regions (Arnison et al., 2013). The LP region
is highly conserved among a family of precursor peptides (Lei-
koski et al., 2013; Oman and van der Donk, 2010). It has been
proposed that the LP region acts as a recognition motif for
cognate cyclodehydratase(s), as a cis-acting chaperone, and/
or as a secretion signal (Madison et al., 1997; Oman and van
der Donk, 2010; Yorgey et al., 1993). The C/S/T residues present
in the LP region are unmodified by the cognate cyclodehy-
dratase, whereas those in the core region selectively undergo
cyclodehydration to yield the corresponding Az-peptide. In
some precursor peptide families, in addition to a specific core
region, several homologs can also be modified by a single
species of cyclodehydratase (Donia et al., 2006). This property
of cyclodehydratase is presumably advantageous for generating
a set of secondary metabolites with minimal codon alterations in
the precursor peptide genes.
Mutagenesis studies on precursor peptides have been
performed to gain insight into the substrate tolerance and spec-
ificity of cyclodehydratase-associated biosynthesis (Bowers
et al., 2012; Deane et al., 2013; Dunbar et al., 2012; Madison
et al., 1997; Melby et al., 2012; Sinha Roy et al., 1998;
Young et al., 2012). Walsh and coworkers conducted muta-
genesis studies on the microcin B17 precursor (Li et al., 1996;
Yorgey et al., 1994), which is modified by cyclodehydratase
McbB/C, and they elegantly revealed the critical determinants
of substrate recognition as follows (Madison et al., 1997; Sinha
Roy et al., 1998): (1) the LP region is essential for themodification
event, (2) only C and S in the core region are modified by the
enzyme (i.e., T was not efficiently modified), and (3) in the modi-
fication of the X1SCX+1 site, in which S and C are successively
cyclodehydrated, the flanking X1 and X+1 residues must be
small amino acid residues, such as G and A. In another example,
Mitchell and coworkers conducted a genome mining study of
Bacillus sp. Al Hakam and discovered a new putative biosyn-
thetic gene cluster involving BalhC/D cyclodehydratase (Dunbar
et al., 2012; Melby et al., 2012). In this system, the cyclodehydra-
tase modifies only the C/S/T residues preceded by G, andLtd All rights reserved
Figure 1. Present Knowledge of PatD Catal-
ysis in Cyanobactin Biosynthesis and the
Concept of the FIT-PatD System
(A) Azoline formation by PatD in the biosynthetic
pathway of cyanobactins. PatD catalyzes cyclo-
dehydration of C/S/T residues present in the CSs
of PatE and installs azoline structures into the
polyamide backbone. The resulting Az-peptide is
further modified by other processing enzymes and
eventually converted to mature cyanobactins.
(Although ‘‘thiazole/oxazole-modified microcins’’
was recently introduced as a similar term, we use
the name ‘‘Az-peptides’’ in this article because we
feature peptides containing azolines rather than
azoles, and we discuss Az-peptides including
artificial ones that would not exhibit definite bio-
activities, which are not included inmicrocins.) The
N-terminal LP region, uRS, dRS, modifying C/S/T
residues in the CS, and intact residues in the CS
are shown in gray, black, brown, red, and blue,
respectively.
(B) In vitro Az-peptide synthesis in the FIT-PatD
system. A custom-made in vitro translation system
in which RNA polymerase, a set of translation
factors and enzymes, ribosome, and PatD are
included; this FIT-PatD system allows ‘‘one-pot’’
synthesis of Az-peptides from the cognate DNA
templates.
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regions from the C terminus. These studies demonstrate that
although the cyclodehydratases can accept some engineered
substrates, their substrate tolerance is limited by their prefer-
ence for the residues to be modified and the adjacent residues.
PatD, coded within the pat gene cluster of Prochloron spp.
cyanobacteria (Schmidt et al., 2005), is amember of the cyclode-
hydratase family and is involved in the biosynthesis of cyanobac-
tins (Degnan et al., 1989; Sivonen et al., 2010) that belong to a
class of thiazole/oxazole-modified microcins (Melby et al.,
2011). PatE, the naturally occurring substrate of PatD, consists
of an N-terminal LP region, three recognition sequences (RSs),
and two core sequences (CSs), aligned in the order LP-RS-CS-
RS-CS-RS (Figure 1A) (Leikoski et al., 2013; Schmidt et al.,
2005). The amino acid sequences of the CSs, which are the
core regions in this system, are different, and both undergo
cyclodehydration by PatD. The resulting azoline-incorporated
CSs are further oxidized and macrocyclized by other modifying
enzymes, PatG and PatA, to yield mature cyanobactins (Schmidt
et al., 2005). Although the PatD cyclodehydration process shares
similarities with those of McbB/C and BalhC/D, the sequence
composition of PatE differs from the substrates of these
enzymes, implying a unique substrate recognition mechanism
and tolerance in PatD catalysis. A recent metagenomic analysis
revealed the existence of several genes homologous to the PatE
gene, which contains highly conserved LP and RS domains (Do-
nia et al., 2008; Leikoski et al., 2013). Although these putativeChemistry & Biology 21, 766–774, June 19, 2014precursor peptides have various CSs,
the residues flanking C/S/T in the CSs
consist predominantly of hydrophobic
alkyl amino acids (A, V, L, I, P, and M) oraromatic amino acids (F, Y, and H) (Figure S1 available online).
Thus, knowledge regarding the requirements for LPs and RSs
as well as the expandability of CSs to nonhydrophobic residues
remains largely limited.
Here we have integrated PatD with a custom-made re-
constituted cell-free translation system, referred to as the FIT
(flexible in vitro translation) system (Goto et al., 2011) (Figure 1B),
and performed extensive mutagenesis and deletion analyses
of PatE. This in vitro biosynthesis system, FIT-PatD, allowed
us to more rapidly and readily construct a wide array of PatE
variants expressed from designed DNA templates, compared
with conventional methods (Roy et al., 1999a; Sinha Roy et al.,
1998). We have identified the substrate recognition determi-
nants for PatD catalysis using the FIT-PatD system, unveiling
unique in vitro substrate tolerance of PatD. The results not
only provide a better understanding of the inherent ability of
this unique secondary-metabolite biosynthesis but also reveal
its technological potential for producing a wider range of Az-
peptides.
RESULTS
Integration of the FIT System with PatD
Cyclodehydration of engineered PatE sequences has previously
been examined either by in vitro PatD reactions with PatE
variants heterologously expressed and isolated from Escherichia
coli or by coexpression of PatE variants and TruD, a PatDª2014 Elsevier Ltd All rights reserved 767
Figure 2. Synthesis of a Model Az-Peptide in the FIT-PatD System
(A) Amino acid sequence of a model substrate bearing a single CS (PatE-1CS).
(B) Mass spectra of unmodified and modified PatE-1CS generated in the FIT-
PatD system. The spectra in black and blue correspond to a precursor peptide
synthesized in the ordinary FIT system (without PatD) and an Az-peptide
generated from the FIT-expressing precursor peptide upon the treatment with
PatD, respectively. The spectrum in red shows the sameAz-peptide product of
one-step synthesis in the FIT system containing PatD. Calculated and
observed mass values are summarized in Table S2.
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family has some tolerance for PatE variants (Koehnke et al.,
2013; McIntosh et al., 2010; McIntosh and Schmidt, 2010; Tia-
nero et al., 2012). However, the labor-intensive preparation of
substrates and isolation of Az-peptide products allows the inves-
tigation of limited numbers of subsets of their variation. To in-
crease the throughput of mutagenesis on PatE, we used the
FIT system (Goto et al., 2011), consisting of a custom-reconsti-
tuted in vitro translation system (Shimizu et al., 2005) and a flex-
ible tRNA acylation ribozyme, so-called flexizyme (Murakami
et al., 2006). The coupled transcription and translation of the
FIT system can express PatE variants directly from their syn-
thetic DNA template, thus largely facilitating the generation of
substrate variants and analysis of Az-peptides.
To establish the FIT-PatD system, we first verified that recom-
binant PatD couldmodify a near-native PatE variant expressed in
the FIT system. We designed a DNA template encoding a short
precursor peptide consisting of LP-RS-CS-RS (PatE-1CS), in
which the single CS region containing two each of C and T
residues was flanked by two RS regions (Figure 2A). Upon
expression of the DNA template in the FIT system, the product
was analyzed by MALDI-TOF mass spectrometry (MALDI-TOF-
MS), demonstrating that the expected PatE-1CS was produced
without any detectable side products (Figure 2B, black line).
When 6 mM of PatD was incubated with the crude PatE-1CS at
25C for 14 hr, the original PatE-1CS peak was replaced with a
peak corresponding to a 72 Da decrease in molecular mass (Fig-
ure 2B, blue line). This observation was consistent with a loss of
four water molecules and indicated that the four C/T residues in
the CS had been cyclodehydrated to yield the expected Az-pep-
tide with two thiazolines and twomethyloxazolines. Themodified
PatE-1CS peptide was digested with Glu-C endopeptidase, and
the resulting C-terminal peptide fragment was subjected to
tandem mass spectrometry (MALDI-TOF/TOF) (Figure S2A).
The resulting fragmentation pattern further confirmed the forma-768 Chemistry & Biology 21, 766–774, June 19, 2014 ª2014 Elseviertion of the four expected azoline moieties. We next performed
‘‘one-pot’’ synthesis of the Az-peptide in the FIT system in the
presence of PatD. The desired peak corresponding to the Az-
peptide was detected on MALDI-TOF-MS (Figure 2B, red line).
Because of the facility of altering the sequences of precursor
peptides expressed in the FIT-PatD system and detecting the
Az-peptide products by MALDI-TOF-MS, we envisaged the util-
ity of this system for extensivemutagenesis studies on PatE-1CS
in in vitro PatD catalysis.
The Role of RSs in PatE for PatD Modification
The CSs in the native PatE are flanked by conserved G(L/V)E
(A/P)S and AYDG(E/V) motifs (Donia et al., 2006; Schmidt
et al., 2005). Recent biochemical and structural studies on
PatA and PatG have shown that the conserved upstream RS
(uRS) and downstream RS (dRS) in the native PatE (Figure 1A)
play a role in defining the proteolytic sites in themacrocyclization
of the CS (Agarwal et al., 2012; Koehnke et al., 2012; Lee et al.,
2009). Therefore, it was postulated that the uRS and dRS are
the sequence elements designating the core regions in cyano-
bactin biosynthesis. We here applied the FIT-PatD system to
an investigation of the role of the uRS and dRS in in vitro PatD
catalysis.
We designed a series of PatE-1CS mutants with altered
uRS and dRS (Figure 3A). When a mutant lacking the dRS
(DdRS) was expressed in the FIT-PatD system, all four C/T
residues were cyclodehydrated, indicating that the dRS was
not essential for PatD catalysis (Figure 3A, entry 2; Figure S3B).
In contrast, deletion of the uRS (DuRS) decreased the efficiency
of cyclodehydration, leaving one or two intact C/T residues (Fig-
ures 3A, entry 3, and 3B). This suggested that even though the
uRSwas not essential for an active substrate, it played an impor-
tant role in catalytic efficiency. To identify the cyclodehydration
sites, the Glu-C digested fragment of the modified DuRS
peptide, which contains three azolines, was analyzed by using
MALDI-TOF/TOF (Figure S2B). The observed fragmentations
indicated that PatD was unable to modify the T residue closest
to the LP region but was able to modify the other T and two C
residues.
On the basis of the above results, we speculated that the
uRS played a role as a spacer between the LP and CS
rather than interacting with PatD as a specific sequence motif.
To verify this hypothesis, we constructed precursor peptides
whose uRS regions were substituted with pentaglycine (G5),
pentaglutamine (Q5), pentaproline (P5), pentaglutamate (E5), or
pentalysine (K5) (Figure 3A, entries 4–8; Figures S3C–S3G).
These precursor peptides turned out to be fully modified after in-
cubation with PatD, supporting the above hypothesis. We also
constructed a precursor peptide with G5 inserted between the
LP and uRS (G5-uRS) (Figures 3A, entry 9, and 3C). MALDI-
TOF analysis of the product showed a total of five cyclodehydra-
tions, very likely originating from the modifications of a S residue
in the native uRS in addition to the four expected residues. This
observation suggested that the S residue in the native uRS
became a part of the CS by the insertion of the G5 spacer
between the LP and uRS. Taken together, we concluded that
the uRS in PatE acts as an arbitrary spacer between the LP
and CS in the in vitro PatD reaction rather than as a specific
RS motif for PatD.Ltd All rights reserved
Figure 3. Studies on the uRS and dRS in
PatD Catalysis
(A) RS mutants tested in this study. Dashed lines
and purple residues indicate deleted and
substituted or inserted residues, respectively. Red
pentagons indicate the sites of azoline formation.
Numbers of observed cyclodehydration are
shown in the table. For mass spectra of mutants
labeled with asterisks, see Figure S3.
(B and C) Mass spectra of DuRS (B) and G5-uRS
(C). Spectra in black and red correspond to the
precursor peptide and Az-peptide synthesized in
the FIT and FIT-PatD systems, respectively. All
variants were incubated with 6 mM PatD for 14 hr.
Calculated and observed mass values are sum-
marized in Table S2.
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The LP region is also highly conserved among cyanobactin
precursors, implying that it has an important role in biosynthesis
involving PatD (Donia et al., 2006; Houssen et al., 2010; Leikoski
et al., 2013). Because such LPs are commonly present in many
precursor peptides in posttranslational modification systems, it
has been postulated that they play a specific or multiple
roles in posttranslational modification processes, such as an
enzyme-recognition motif, a cis-acting chaperone, and/or a
secretion signal (Madison et al., 1997; Neis et al., 1997; Oman
and van der Donk, 2010; Yorgey et al., 1993).
To assess the importance of the LP region in PatD catalysis,
we first introduced systematic deletions into the LP region of
PatE-1CS and expressed the individual peptides in the FIT-
PatD system. The series of LP-truncated mutants summarized
in Figure 4A and Figure S4 revealed the importance of the LP
C-terminal region. The substrates lacking the LP C-terminal
portion (G20–A37) resulted in the Az-peptide with only a single
cyclodehydrated residue (Figure 4A, entries 2 and 3). In contrast,
the LP region consisting of G11–A37 (Figure 4A, entry 4) resulted
in the fully (quadruply) modified Az-peptide as efficiently as with
the full-length LP region. To our surprise, two LP mutants con-
sisting of only six amino acids (Figure 4A, entries 6 and 7) were
also modified by PatD to yield the fully modified Az-peptide,
accompanied by partially modified Az-peptides (with two or
three modifications). These results indicated that the C-terminal
region of LP was important for active PatE substrates.
On the basis of the above information, we next attempted to
further define critical residues within the C-terminal region of
LP by means of point and multiple-site mutagenesis of PatE-
1CS. To enhance the mutagenesis effect, the PatD concentra-
tion was lowered from 6 to 0.6 mM, and the reaction time was
shortened from 14 to 2 hr. We first performed a point mutationChemistry & Biology 21, 766–774, June 19, 2014in every residue within the L26–A37
region with alanine (A), asparagine (N),
or glutamine (Q) (Figure 4B, entries 2–5;
Figure S6, entries 2–20). In A and N point
mutation studies, we found that two
residues, L29 and L34, reduced themodi-
fication efficiency, while the latter muta-
tion had more pronounced effect. To our
surprise, the point mutation of acidic res-idues E28Q, E31Q, E32Q, and D36N had no negative effect on
efficiency. Double mutations of the critical residues, L29N/
L34N, yielded a singly cyclodehydrated peptide, while other
double mutations, such as E28Q/E31Q and E31Q/E32Q, had a
marginal negative effect (Figure 4B, entries 6–8; Figure S6,
entries 21–27), indicating that L29 and L34 were far less tolerant
in mutations compared with others. On the other hand, triple Q
mutations of the acidic cluster in E28, E31, and E32 largely
reduced modification efficiency (Figure 4B, entries 9–11; Fig-
ure S6, entries 28–32). Intriguingly, quadruple mutations of the
C-terminal region of LPwith P residues, which presumably broke
the a-helical secondary structure, did not affect modification
efficiency (Figure 4B, entry 12). These results have revealed
that in LP, (1) L34 is essential; (2) L29 is important but less critical
than L34; (3) the acidic cluster of E28, E31, and E32 is coopera-
tively important; and (4) the a-helical secondary structure is
unimportant.
Although the LP C-terminal region was necessary for the
full conversion of PatE to Az-peptides, we observed a single
cyclodehydration even in the LP mutants lacking the C-terminal
region (Figure 4A, entries 2 and 3; Figure S4, entries 2–7).
Therefore, we tested a mutant lacking the entire LP region
(DLP), that is, a precursor peptide consisting of uRS-CS-dRS.
PatD modified a single residue in the DLP substrate along with
some doublemodifications (Figure 4C, entry 1; Figure S5U), indi-
cating that the LP region of the precursor peptide was not an
essential determinant for an active substrate. Supplementing
the PatD-DLP reactionwith the full-length LP fragment enhanced
the degree of cyclodehydration, yielding a mixture of fully
(quadruply) and triply modified Az-peptides (Figure 4C, entry 2;
Figure S5V). This suggested that LP is a trans-acting chaperone
of PatD rather than an essential cis element of the PatE substrate
for recruiting PatD.ª2014 Elsevier Ltd All rights reserved 769
Figure 4. Studies on the LP Region in PatD
Catalysis
(A) Selected LP deletion mutants. The PatE vari-
ants were incubated with 6 mM PatD for 14 hr.
Dashed lines denote deleted residues in LP, and
the ‘‘# of modified residues’’ column indicates the
numbers of modified residues observed in MALDI-
TOF spectra (Figure S5) of the Az-peptide(s). A full
set of LP deletion mutants is shown in Figure S4.
(B) Selected point and multiple-site mutants. The
PatE variants were incubated with 0.6 mMPatD for
2 hr. Mutated residues are shown in black bold
characters. The C-terminal region of LP (residues
26–37), to which extensive mutations were intro-
duced, is underlined in entry 1. Hydrophobic and
acidic residues present in this region are shown in
green and purple, respectively, and the essential
five residues identified by this analysis are under-
lined with red lines. A full set of point and multiple-
site mutants is shown in Figure S6. For mass
spectra of these mutants, see Figures S7 and S8.
(C) PatD modification of a precursor peptide
lacking the entire LP region with and without trans-
presenting LP. The PatE variants were incubated
with 6 mMPatD for 14 hr. The corresponding mass
spectra are shown in Figure S5.
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Recent genome mining of Prochloron spp. has revealed a
series of different CS components in PatE homologs (Donia
et al., 2006; Leikoski et al., 2013). Although this suggests
tolerance of PatD toward such CS variants, the sequences are
biased toward the following trends (Figure S1): (1) CS lengths
are limited to six to eight residues, (2) CSs consist primarily of
hydrophobic and/or aromatic residues, and (3) successive C/S/
T residues to be modified are not found, in contrast to the cyclo-
dehydratase McbB/C system, in which successive azolines are
formed (Li et al., 1996). Although it has been reported that
TruD can modify engineered CSs containing nonnatural phenyl-
alanine analogs (Tianero et al., 2012), their sequence com-
position also followed these trends. Therefore, tolerance of
PatD toward CS motifs beyond the naturally observed trends
was unknown.
To gain insight into the in vitro substrate tolerance of PatD,
we designed precursor peptides having a wide variety of nonca-
nonical CSs. These CS mutants were expressed in the FIT-PatD
system, and their degrees of modifications were analyzed
(Table 1; Table S1). This analysis revealed the following extraor-
dinary properties of PatD: (1) PatD accepted diverse CS lengths
as short as two residues with a single modifiable site and as long
as 36 residues with 18 modifiable sites (Table 1, entries 2–7;
Table S1, entries 1–9); (2) PatD was capable of modifying any
of the C/S/T residues, but C was the most efficiently modified
(Table 1, entries 8–10; Table S1, entries 26–35); (3) PatDmodified
residues independently of the sequence context (i.e., even those770 Chemistry & Biology 21, 766–774, June 19, 2014 ª2014 Elsevier Ltd All rights reservedwith adjacent nonhydrophobic resides
could be modified) (Table 1, entries
11–17; Table S1, entries 10–25); and (4)
PatD modified consecutive residues to
yield successive azolines (Table 1, entries19–21). Taken together, these results indicate that PatD has
remarkable substrate tolerance toward a wide array of CSs.
PatD Modification of Short Precursor Peptides
Consisting of Engineered LP, Linker, CSs, and
Terminator
On the basis of our knowledge of the minimal PatD substrate
composition, we designed two engineered precursor peptides
for transformation to Az-peptides by PatD catalysis. The
construct sLS-G5-CS4-A was composed of a short (13-mer)
LP region and a G5 linker (sLP-linker), followed by a tetramer
CS with two C residues, and terminating with a single A. The
construct sLS-G5-CS16-A consisted of a 16-mer CS with eight
C residues flanked by the sLP-linker and terminator. In both
cases, the FIT-PatD system yielded the expected fully modified
Az-peptides (Figures 5A and 5B). These results demonstrated
that precursor peptides consisting of the sLP-linker and nonca-
nonical CSs were compatible with PatD catalysis.
DISCUSSION
Ourmutagenesis studies using the FIT-PatD system have shown
that the conserved sequence motifs in the native PatE are not
necessarily essential for the cyclodehydration reaction step
catalyzed by PatD in vitro. Our experiments provide the following
insights (Figure 6): (1) LP can act not only as a cis but also as a
trans element, enabling us to postulate that it plays a role in
PatD activation; (2) the residues in the C-terminal region of LP,
Table 1. Studies on the CS Region in PatD Catalysis
Entry Sequence Name Cassette Sequence Possible Maximum Modifications No. of Modified Residues
1 PatE-1CS (WT) VTACITFC 4 4
2 CS-2 VC 1 1
3 CS-4 VCAC 2 2
4 CS-14 VCACICFCVCACVC 7 7
5 CS-16 VCACICFCVCACVCIC 8 8
6 CS-22 VCACICFCVCACVCICYCFCIC 11 11
7 CS-36 VCACICFCVCACVCICYCFCICFCACVCICYCFCIC 18 18
8 CS-allC VCACICFC 4 4
9 CS-allT VTATITFT 4 4, 3, 2
10 CS-allS VSASISFS 4 4, 3, 2
11 CS-I5D VTACDTFC 4 4
12 CS-I5N VTACNTFC 4 4
13 CS-I5K VTACKTFC 4 4
14 CS-14-1R3R RCRCICFCVCACVC 7 7, 6
15 CS-14-7R9R VCACICRCRCACVC 7 7, 6
16 CS-14-11R13R VCACICFCVCRCRC 7 7
17 CS-R2D2 RCDCDCRC 4 3
18 CS-C VFALIMFC 1 1
19 CS-CC VFALIMCC 2 2
20 CS-CCC VFALICCC 3 3
21 CS-CCCC VFALCCCC 4 4
C/S/T residues in CS are shown in italics. All variants were incubated with 6 mM PatD for 14 hr. The ‘‘No. of Modified Residues’’ column indicates the
numbers of modified residues observed in MALDI-TOF spectra (Figure S9) of the Az-peptide(s). Additional CS mutants are also shown in Table S1.
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function of LP; (3) the uRS acts as a spacer sequence whose
primary role is to accommodate the downstream CS in the
PatD active site; (4) the dRS is largely dispensable; and (5) a
wide variety of functional CSs can be designed that expand on
the naturally observed CS trends.
Our data, generated by extensive deletion and mutagenesis
studies (Figures 4A and 4B), revealed that L29/L34 and acidic
clusters in the C-terminal region are critical to retain the sub-
strate activity. Indeed, the residues at the 28th to 34th positions
are highly conserved in the cyanobactin precursor peptide family
(Leikoski et al., 2013). Intriguingly, we observed that partial LP
deletion mutants retaining the N-terminal region (Figure S4,
entries 2–7) exhibited lower modification efficiencies than the
complete LP deletion mutant, DLP (Figure 4C, entry 1). This
means that the N-terminal LP region containing hydrophilic
and basic residues could weakly inhibit PatD, which also indi-
rectly suggests that the above sequence in the C-terminal region
is the specific activator of PatD. Note that the observed full reten-
tion of the modification efficiency in an a-helix-broken mutant by
proline substitutions (Figure 4B, entry 12) has contradicted
previously reported data in which LP alone has an a-helical
conformation in 50% aqueous trifluoroethanol (Houssen et al.,
2010). Because our data reflect the functional importance of
LP, we conclude that the a-helical secondary structure of LP is
not critical for the activation of PatD when the critical L29/L34
and the acidic cluster are present in the C-terminal region.
With regard to the hypothesis that LP is an activator of PatD,we
propose that without LP, PatD remains in a passive state (Fig-Chemistry & Biology 21,ure 6). This passive state may be important for preventing indis-
criminate modification of the proteome. Binding of LP activates
PatD’s catalytic ability, leading to the selective modification of
precursorpeptides. It shouldbenoted that our hypothesis ispartly
contradictory toamodel recentlyproposed for TruD (ahomologof
PatD), inwhich the LP is not involved in the recognition of theCS’s
C-terminal Cys residue but is necessary for modification of the
interior Cys residues (Koehnke et al., 2013). Our observation for
the trans-activity of LP in the PatD catalysis suggests that the
LP simply acts as an activator of PatD. We cannot yet rule out a
possibility that this observation is limited to the in vitro activity of
PatD or possibly related enzymes. However, similar observations
of such trans-acting LPs have been also reported for lantibiotic
and thiazole/oxazole-modified microcin biosynthetic systems
(Dunbar and Mitchell, 2013; Khusainov and Kuipers, 2012;
Oman et al., 2012; Patton et al., 2008). Thus, such an activation
mechanism may be generic for the biosynthesis of ribosomally
synthesized and posttranslationally modified peptides.
We have also observed that PatD accepts not only the natu-
rally conserved G(L/V)E(A/P)S motif of the uRS but also other
sequence motifs, such as G5, Q5, P5, E5, and K5 (Figure 3A,
entries 4–8). Moreover, the dRS is completely dispensable (Fig-
ure 3A, entry 2). These observations imply that PatD does not rely
on specific sequences in the CS flanking regions but rather can
adapt to the RS requirements of other enzymes (Agarwal et al.,
2012; Koehnke et al., 2012; Lee et al., 2009) in the biosynthesis
of cyanobactins.
Naturally occurring PatE derivatives have a smaller set of
sequence variations compared with the possible PatD766–774, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 771
Figure 5. PatD Modification of Short Pre-
cursor Peptides Consisting of Engineered
LP, Linker, CSs, and Terminator
(A and B) The engineered short precursor pep-
tides, (A) sLS-G5-CS4-A and (B) sLS-G5-CS16-A,
with their corresponding Az-peptides. Spectra in
black and red correspond to the designed sub-
strates without and with PatD treatment, respec-
tively. The peptides were incubated with 6 mM
PatD for 14 hr. The mass peak of the precursor
sLS-G5-CS16-A peptide was undetectable,
because cysteine-rich peptides are often difficult
to recover in SPE desalting or to ionize on MALDI-
TOF, resulting in very poor signal detection.
Calculated and observed mass values are sum-
marized in Table S2.
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Cell-free Synthesis of Azoline-Containing Peptidessubstrates demonstrated in this study. The selection and
evolution of precursor peptides that could produce secondary
metabolites with favorable bioactivities may have resulted in
the biased sequence variation in nature. Alternatively, the sub-
sequent enzyme reaction catalyzed by PatGmay have less toler-
ance to the sequence variation. We also cannot rule out another
possibility: that because the experiments in this study were per-
formed in vitro under conditions in which a stoichiometric or an
excess amount of PatD was used in the FIT-PatD system, the
high substrate tolerance to LP, RS, and CS mutants observed
in this study may not be necessarily applicable to in vivo reac-
tions. Nevertheless, the present data show the remarkable cata-
lytic potential toward a variety of PatE derivatives, at least in vitro.
Moreover, the FIT-PatD system is applicable to the synthesis of
diverse kinds of Az-peptides containing not only proteinogenic
amino acids but also nonproteinogenic amino acids incorporated
by the genetic code reprogrammingmethodology. In particular, a
potential use of the FIT-PatD system is an integration with mRNA
display (Hayashi et al., 2012; Hipolito and Suga, 2012; Kawakami
et al., 2013; Kawakami and Murakami, 2012; Kodan et al., 2014;
Morimoto et al., 2012; Nemoto et al., 1997; Passioura et al., 2014;
Roberts and Szostak, 1997; Tanaka et al., 2013; Yamagishi et al.,
2011), which will provide an opportunity to select bioactive Az-
peptides against therapeutic targets from their libraries with
extraordinarily high complexity. This is our clear direction of the
future development of the FIT-PatD system.
In summary, we have established an in vitro FIT-PatD system
that facilitates not only investigation of the sequence require-
ments of the substrate peptides but also generation of diverse
Az-peptides. In principle, the FIT system can be coupled with
other posttranslational modification enzymes, and such in vitro
systems allow us to accelerate studies on their biosynthesis
and expanding the chemical diversity of natural products as
‘‘pseudonatural products.’’
SIGNIFICANCE
The FIT-PatD system, an in vitro biosynthetic system for Az-
peptides, was established by integrating a posttranslational
cyclodehydratase PatD with a FIT system. The FIT-PatD
system allows us to express diverse substrate variants and
test their modification efficiencies in a one-pot fashion.
Extensive mutagenesis and deletion analyses of PatD sub-
strate identified the substrate recognition determinants for772 Chemistry & Biology 21, 766–774, June 19, 2014 ª2014 ElsevierPatD catalysis. The high substrate tolerance of PatD implies
that the FIT-PatD system could be a powerful tool to pro-
duce a wider array of Az-peptides.
EXPERIMENTAL PROCEDURES
Preparation of DNA Templates Coding PatE Mutants
Double-strand DNA templates coding PatE mutants, which are used for Az-
peptide synthesis in the FIT-PatD system, were prepared using multistep
PCR (method A) or primer extension followed by multistep PCR (method B).
Primers and PCR templates used for the construction of DNA templates are
summarized in Table S3. Sequences of all primers used in this study are listed
in Table S4. The PCR mixture used in this study contained 10 mM Tris$HCl
(pH 9.0), 50 mM KCl, 2.5 mM MgCl2, 0.25 mM deoxyribonucleotide triphos-
phates, 0.1% (v/v) Triton X-100, and Taq DNA polymerase.
In method A, from the first to the penultimate PCR, an appropriate template
DNA (see Table S3) was amplified using the designated forward and reverse
primers (1mMeach).PCRwasconductedwitha100ml scaleby5cyclesofdena-
turing (95C for 40 s), annealing (50C for 40 s), and extending (72C for 40 s).
When the plasmid was used as a template DNA, the PCR cycle was increased
to 20 cycles. The resulting PCRmixturewas 200-fold diluted andused as a tem-
plateDNA for the followingPCRstep. ThefinalPCRwasconductedwitha 200ml
scale by 12 to 25 cycles of denaturing (95C for 40 s), annealing (50C for 40 s),
and extending (72C for 40 s) and final extension at 72C for 3 min.
In method B, for primer extension, appropriate forward and reverse primers
(1 mM each; see Table S3 for further information) were mixed in the PCR
mixture. The primer extension reaction was conducted with a 100 ml scale
by denaturing (95C for 1 min), followed by 5 cycles of annealing (50C for
1 min) and extending (72C for 1 min). The resulting reaction mixture was
200-fold diluted and used as a template DNA for the following PCR step.
From the first to the penultimate PCR, the template DNA (the product of the
preceding extension reaction or PCR) was amplified using the designated for-
ward and reverse primers (1 mM each; see Table S3 for further information).
PCR was conducted with a 100 ml scale by 5 cycles of denaturing (95C for
40 s), annealing (50C for 40 s), and extending (72C for 40 s). The resulting
PCR mixture was 200-fold diluted and used as a template DNA for the
following PCR step. The final PCR was conducted with a 200 ml scale by 12
to 25 cycles of denaturing (95C for 40 s), annealing (50C for 40 s), and ex-
tending (72C for 40 s) and final extension at 72C for 3 min.
Amplification of the final PCR product was checked by agarose gel electro-
phoresis. The resulting DNA was purified by phenol/chloroform extraction and
ethanol precipitation and then dissolved in 20 ml of water (giving a 0.1–0.6 mM
solution) and directly used without adjustment of concentration for in vitro
translation reaction using the FIT-PatD system.
FIT-PatD System
Translation factors, enzymes, and ribosome were prepared and mixed as pre-
viously described to reconstitute an in vitro transcription-translation coupled
system (Goto et al., 2011). The reactionmixture contained a final concentration
of 50 mM HEPES$K (pH 7.6), 100 mM KOAc, 2 mM guanosine triphosphate,Ltd All rights reserved
Figure 6. A Model for the Interaction of PatD with the Substrate
The LP region, uRS, and dRS are shown in gray, black, and brown, respec-
tively. In the CS, residuesmodified by PatD are shown in red, while unmodified
residues are shown in blue. The C-terminal region of LP (minimal LP) activates
PatD upon its binding, and the uRS acts as a spacer accommodating the
downstream CS to the PatD active site. Diverse CS compositions can be
cyclodehydrated by PatD.
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Cell-free Synthesis of Azoline-Containing Peptides2 mM ATP, 1 mM cytidine triphosphate, 1 mM uridine triphosphate, 20 mM
creatine phosphate, 12 mM Mg(OAc)2, 2 mM spermidine, 2 mM dithiothreitol
(DTT), 1.5 mg/ml E. coli total tRNA (Roche), 1.2 mM ribosome, 0.6 mM
methionyl-tRNA formyltransferase, 2.7 mM IF1, 0.4 mM IF2, 1.5 mM IF3,
30 mM EF-Tu, 30 mM EF-Ts, 0.26 mM EF-G, 0.25 mM RF2, 0.17 mM RF3,
0.5 mM RRF, 4 mg/ml creatine kinase, 3 mg/ml myokinase, 0.1 mM pyrophos-
phatase, 0.1 mM nucleotide-diphosphatase kinase, 0.1 mM T7 RNA polymer-
ase, 0.73 mM AlaRS, 0.03 mM ArgRS, 0.38 mM AsnRS, 0.13 mM AspRS,
0.02 mM CysRS, 0.06 mM GlnRS, 0.23 mM GluRS, 0.09 mM GlyRS, 0.02 mM
HisRS, 0.4 mM IleRS, 0.04 mM LeuRS, 0.11 mM LysRS, 0.03 mM MetRS,
0.68 mM PheRS, 0.16 mM ProRS, 0.04 mM SerRS, 0.09 mM ThrRS, 0.03 mM
TrpRS, 0.02 mM TyrRS, 0.02 mM ValRS, 200 mM each proteinogenic amino
acids, and 100 mM 10-HCO-H4folate.
In the two-step method, the translation reaction was performed at 37C for
30min at a 2.5 ml scale that contained 0.25 ml of DNA template. To the resulting
translation mixture (2.5 ml) was added 2.5 ml of PatD mixture I (12 mM PatD,
90 mM HEPES$K [pH 8.4], 16 mM DTT, and 1 mM ATP), and the mixture
was further incubated at 25C for 14 hr. For the point and multiple-site
mutagenesis analysis of LP, the translated PatE variants were incubated
with 0.6 mM PatD at 25C for 2 hr.
In the one-pot method, modified reaction mixture was used; 6 mMPatD was
added, and the concentrations of HEPES buffer, DTT, and ATP were changed
to 95 mM (pH 8.0), 10 mM, and 2.5 mM, respectively. DNA template (0.25 ml)
was incubated in the reaction mixture (2.5 ml) at 37C for 30 min, followed by
at 25C for 14 hr.
For precursor peptide synthesis without PatD treatment, the translation
reaction was performed at 37C for 30 min at a 2.5 ml scale that contained
0.25 ml of DNA template. To the resulting translation mixture (2.5 ml) was added
2.5 ml of a buffer (90 mM HEPES$K [pH 8.4], 16 mM DTT, and 1 mM ATP), and
the mixture stood at 25C for 14 hr as a control before analyzing the peptide
using MALDI-TOF-MS.
Mass Spectrometry of Precursor Peptides and Az-Peptides
Synthesized in the FIT-PatD System
The translation mixture or FIT-PatD reaction mixture was desalted with a solid
phase extraction (SPE) column (C-TipC18;Nikkyo Technos) and elutedwithma-
trixsolution (80%acetonitrile, 0.5%aceticacid, andhalf-saturatedmatrix).As the
matrix, sinapinic acid and a-cyano-4-hydroxycinnamic acid (Bruker Daltonics)
was used for products above and below 4,500 Da, respectively. MALDI-TOF-
MS was carried out on an autoflex II TOF/TOF (Bruker Daltonics) or an ultrafle
Xtreme (Bruker Daltonics) externally calibrated with protein calibration standard
I (Bruker Daltonics) or peptide calibration standard II (Bruker Daltonics).
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